For the main therapy of uterovaginal prolapse, compare prolapse recurrence following complete vaginal hysterectomy with uterosacral ligament suspension to recurrence after supracervical hysterectomy with mesh sacrocervicopexy. From 2009 to 2019, researchers conducted a retrospective cohort analysis of women having uterovaginal prolapse correction at an academic centre. The study comprised women who had vaginal hysterectomy with uterosacral ligament suspension or laparoscopic supracervical hysterectomy with mesh sacrocervicopexy. The primary outcome was a recurrence of composite prolapse. Mesh problems, duration to recurrence, and total reoperation for either prolapse recurrence or mesh complication were secondary outcomes. Researchers utilised propensity scoring with a sacrocervicopexy to uterosacral suspension ratio of 2:1. The study included 654 patients, 228 of whom had uterosacral suspension and 426 had sacrocervicopexy. The sacrocervicopexy group had a longer median follow-up period, although both groups had less than a year. The uterosacral group had a higher percentage of composite prolapse recurrence and recurrent prolapse retreatment. On multivariate Cox regression, the uterosacral group had a shorter time to prolapse recurrence. The sacrocervicopexy group had 14 mesh problems.
When compared to supracervical hysterectomy with mesh sacrocervicopexy, total vaginal hysterectomy with uterosacral ligament suspension was linked with a greater risk of and shorter time to prolapse recurrence.
